Dissecting ARL15 Function in Rheumatoid Arthritis: Insights From Ex Vivo and in Vitro Synovial Fibroblast Models

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation and damage.
• A genome-wide association study (GWAS) identified ARL15 as a non-HLA susceptibility gene for RA in a North Indian cohort.
• Elevated serum adiponectin and ARL15 levels were observed in RA patients with the associated genotype.

Purpose of the Study:

• To investigate the functional role of ARL15 in the pathobiology of rheumatoid arthritis.
• To delineate the molecular mechanisms by which ARL15 influences RA pathogenesis.

Main Methods:

• Differential transcriptomics was performed on ex vivo RA synovial fibroblasts (RASF) and in vitro MH7A cells.
• A gene knockdown (KD) approach was employed to study the effects of reduced ARL15 expression.
• Standard bioinformatics pipelines were used for data analysis.

Main Results:

• In RASF, ARL15 KD downregulated COMP (extracellular matrix stabilizer) and upregulated adiponectin and IFN-response genes (IFI6, USP18).
• ARL15 KD also affected genes associated with disease modulation (NPTX1, MX1) and inflammation (CTGF, CD248, PTX3).
• Distinct transcriptomic signatures were observed in MH7A cells, with upregulated cytokines and downregulated inflammatory regulators, indicating a different inflammatory bias.

Conclusions:

• ARL15 has a multifaceted role in regulating connective tissue, inflammation, and immune responses in RA.
• Despite limitations of cell models, ARL15 is identified as a potential therapeutic target for RA.
• Further research in animal models and genomic medicine is warranted to explore ARL15-targeted interventions for RA management.